TAUROLIDIN - ONLY AN ADJUVANT DRUG

Surgical procedures in patients with peritonitis and sepsis have had t he best results caused by focus sanitation with a reduced risk of mort ality. Adjuvant therapies have a lot of possibilities and different wa ys. The used cytokine-antibodies or inhibitors are still lacking of ge neral acceptable results, successful treatments have been published on ly in subgroups. An important drug is taurolidine, an antibacterial ch emotherapeutic drug, in intraperitoneal or intravenous application rou te. The well known immunomodulation from this drug improves the patien t outcome. The overwhelming majority of data suggests a positive thera peutic effect.